The Paradise Ultrasound Renal Denervation (uRDN) system becomes the first and only ultrasound-based renal denervation (RDN) therapy to be granted a distinct category and device
The new ESC Guidelines for Management of Elevated Blood Pressure and Hypertension were presented at the ESC Congress in London and reinforce the safety and
Statement from the AHA in support of Renal Denervation as a hypertension therapy option provides reinforcement that the treatment can have a meaningful positive impact
Availability of the New Technology Add-on Payment (NTAP) will improve access to innovative ultrasound hypertension therapy for patients across the country Palo Alto, Calif.
Durham VA Health Care System in North Carolina is the first site in US to enroll and treat patients in the study collecting real-world data
Palo Alto, California (May 17, 2024) – Hypertension, or high blood pressure, affects nearly half of all Americans and more than one billion people worldwide.
Al Qassimi Hospital Sharjah becomes first in the Middle East to treat patients with innovative new device-based option to help reduce blood pressure. PALO ALTO,
Innovative new treatment option for patients with uncontrolled hypertension now available in the United States PALO ALTO, Calif. — Nov. 10, 2023 — Recor
Approval of the Paradise™ Ultrasound Renal Denervation system makes innovative hypertension treatment available for the first time in the U.S. Palo Alto, Calif. – November
Analysis shows a maintained blood pressure lowering effect with fewer added medications following treatment with the Paradise Ultrasound Renal Denervation system Palo Alto, Calif.
